We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

APH Alliance Pharma Plc

-0.25 (-0.63%)
Last Updated: 13:36:36
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Alliance Pharma Plc LSE:APH London Ordinary Share GB0031030819 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.25 -0.63% 39.20 107,528 13:36:36
Bid Price Offer Price High Price Low Price Open Price
39.00 39.95 39.20 38.50 38.50
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 167.42M 936k 0.0017 226.47 207.96M
Last Trade Time Trade Type Trade Size Trade Price Currency
13:36:37 O 7,518 39.38 GBX

Alliance Pharma (APH) Latest News

Alliance Pharma (APH) Discussions and Chat

Alliance Pharma Forums and Chat

Date Time Title Posts
03/12/202323:34Alliance Pharma pays Dividends2,175
21/8/201816:36A Canadian Stock Worth Watching1
07/11/201615:35Alliance Pharma plc1
15/7/201309:15ALLIANCE PHARMA – 2005 Strong Riser611

Add a New Thread

Alliance Pharma (APH) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type

Alliance Pharma (APH) Top Chat Posts

Top Posts
Posted at 04/12/2023 08:20 by Alliance Pharma Daily Update
Alliance Pharma Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker APH. The last closing price for Alliance Pharma was 39.45p.
Alliance Pharma currently has 540,150,223 shares in issue. The market capitalisation of Alliance Pharma is £207,957,836.
Alliance Pharma has a price to earnings ratio (PE ratio) of 226.47.
This morning APH shares opened at 38.50p
Posted at 21/11/2023 13:35 by monet
Blackhorse Bad move yesterday geeting out of RUA and IKA.
RUA up over 120% and IKA 28%

Blackhorse2320 Nov '23 - 09:50 - 5136 of 5139
0 0 0
Out with profit & going to buy APH

Blackhorse2320 Nov '23 - 11:39 - 3093 of 3140
0 0 0
Money moving to APH
Posted at 18/11/2023 12:37 by blackhorse23
They got takeaway offer 100p per share last year but rejected as share price valued over 140p , very sure some big PHARMA company will offer again
Posted at 17/11/2023 10:18 by blackhorse23
Good dividends yield & profitable healthcare stocks , group received takeover offer last year 100p per share & corporate shareholders rejected that offer & believe share price valuation more than 100p per share . Coming this microeconomic APH will be one of most profitable stocks in LSE with low value share price . So bounce back is coming
Posted at 07/11/2023 11:03 by seagreen
added another small long to my ISA ...I find the fundamentals for a slow share price rather compelling....even makes real money...hey ho ...good new non execs who know the e commerce distribution channels ...opening up in Canada...looking forward to the finals in 2024 there seems no reason that they will not be significantly better
~But WTF do I know
Posted at 14/10/2023 10:24 by tomzimerman
The main factors that determine whether a share price moves up or down are supply and demand. Essentially, if more people want to buy a share than sell it, the price will rise because the share is more sought-after (the 'demand' outstrips the 'supply'). On the other hand, if supply is greater than demand, then the price will fall.
Posted at 05/10/2023 17:46 by cisk
Well, I hope getting the share price over £1 is in their targets:

Peter Butterfield, Chief Executive Officer, has been awarded 851,666 share options.
Andrew Franklin, Chief Financial Officer, has been awarded 568,866 share options.
Jeyan Heper, Chief Operating Officer, has been awarded 861,111 share options (250,000 of which have been awarded pursuant to his joining of the Company earlier this year).

The awards have been granted at nil-cost and become exercisable on 4 October 2026 subject always to continued employment and the satisfaction of performance conditions based on EPS, TSR and ROCE targets.

The net effect of the grant of Share Options and the resultant option holdings are shown in the table below:


Share Options granted

Total no. of options over ordinary shares now held

Peter Butterfield



Andrew Franklin



Jeyan Heper


Posted at 04/10/2023 10:24 by tomzimerman
Come to the conclusion this is a parody account, no one can be that stupid consistently and ignore the share price and constant decline here. Sincerely hope it goes north from here for those genuine investors but have to point out your comments are completely wrong and misleading to anyone reading them.
Posted at 29/9/2023 07:12 by tomzimerman
Watch the share price today
Posted at 30/8/2023 21:25 by blackhorse23
when big buyers ready to invest & buy stocks & share price goes blue , ITS POSITIVE. This is dividend stocks , high dividend yields. At this price if buyers hold for few years , will get all money back FROM DIVIDENDS , meantime share price will be 10 times MULTI BAG ... that's the goal of those institutional investors
Posted at 19/8/2023 21:40 by dartron
Strange that you didn't use the latest trading update. I have provided the pertinent part for you. Released 18th July 2023.

"Free cash flow in the Period was £5.7m higher than the prior period at £10.8m (H1 22: £5.1m) and net debt decreased £7.5m to £94.5m at 30 June 2023 (31 December 2022: £102.0m)"

My opinion here is that, Investors are not selling, the price drops are due to aggressive shorting, trying to cover back the stock that the directors bought (100k), and Dbay have taken (1%).

- Andrew Franklin, the Chief Financial Officer of the Company, purchased 50,988 ordinary shares
- LeCouilliard, the non-executive Chair of the Company, purchased 40,957 ordinary shares
- DBAY Advisors Limited as discretionary investment manager of Fixtaia Limited, Logistics Development Group Plc and DouglasBay Capital IV Fund LP, purchased 5.4M by Aug 11th

Anyone who was concerned about debt and court cases would have sold up months ago. Short started in May. Its accumulation time, but each to their own.

Court case is done, its only an appeal over the fine, which is a max of 7.9m. So guess already baked in to the price. Expect shorters are hoping to exploit the RNS if the appeal fails (Which I think it will fail). One party did not even appeal, sounds banged to rights! (I'm future looking here, they pay the fine and get on with it). Butterfield may still get disqualified, again not my concern. If the CFO is happy to buy 50k shares, it tells me they can navigate this. Maybe they know that they got off lightly! 7.9M is manageable for them to pay I think, even if it is at the expense of the interim dividend.

(From IC)
"Shareholders will take heart from the news that the board has addressed the day-to-day management issue by appointing Jeyan Heper in the newly created post of chief operating officer. Mr Heper is a management veteran who has served in senior positions at Proctor & Gamble, Danone and British American Tobacco."

(IC comment) "Broker Numis forecasts a 2023 price/earnings ratio of 11 for 2023 and expects Alliance to focus on higher-growth ecommerce in the US. That could mean the shares are priced for recovery, but we remain cautious."

From the government press release Feb 2022:

"Alliance Pharmaceuticals Limited and Alliance Pharma plc are jointly and severally liable for £7,900,000"

The appeal has already been heard:

Appeal and the competition law issue of the director disqualification proceedings to be heard before the Competition Appeal Tribunal between 5 and 27 June and 27 July and 4 August:

Schedule here

No publicised outcome yet, though Dbay bought a further 1% after this date (11th Aug). They are pretty smart, don't know if public could attend?

All to play for I think, happy to hold a few under 50p. Short has to cover doesn't it. This could get taken out for twice the current share price IMO.

I hope I have answered the court case questions, which to be fair could have been googled in 30 seconds.
Alliance Pharma share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |